A1171 - Intrinsic molecular urothelial cancer subtypes remain stable during metastatic evolution.

MLA

Cox, A., et al. “A1171 - Intrinsic Molecular Urothelial Cancer Subtypes Remain Stable during Metastatic Evolution.” European Urology, vol. 83, Feb. 2023, pp. S1690–91. EBSCOhost, https://doi.org/10.1016/S0302-2838(23)01209-5.

APA

Cox, A., Klümper, N., Stein, J., Sikic, D., Breyer, J., Bolenz, C., Roghmann, F., Erben, P., Wirtz, R. M., Wullich, B., Ritter, M., Hölzel, M., Schwamborn, K., Horn, T., Gschwend, J., Hartmann, A., Weichert, W., Erlmeier, F., & Eckstein, M. (2023). A1171 - Intrinsic molecular urothelial cancer subtypes remain stable during metastatic evolution. European Urology, 83, S1690–S1691. https://doi.org/10.1016/S0302-2838(23)01209-5

Chicago

Cox, A., N. Klümper, J. Stein, D. Sikic, J. Breyer, C. Bolenz, F. Roghmann, et al. 2023. “A1171 - Intrinsic Molecular Urothelial Cancer Subtypes Remain Stable during Metastatic Evolution.” European Urology 83 (February): S1690–91. doi:10.1016/S0302-2838(23)01209-5.